Bringing Stem Cell Cures to the Clinic: UC Davis GMP Facility

Posted: Published on September 15th, 2011

This post was added by Dr. Richardson



The FDA requires the use of a Good Manufacturing Practice (GMP) facility for taking stem cell-based therapies into clinical trials.

Read more from the original source:
Bringing Stem Cell Cures to the Clinic: UC Davis GMP Facility

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.